Chao Li Phones & Addresses
-
Potomac, MD
-
Germantown, MD
-
Arlington, VA
-
Centreville, VA
Education
School / High School:
New York University, School of Law
Ranks
Licence:
New York - Currently registered
Date:
2009
Resumes
Resumes
Business Analyst At Thomson Reuters
View pagePosition:
Business Analyst at Thomson Reuters
Location:
Beijing City, China
Industry:
Financial Services
Work:
Thomson Reuters - Z-Park, Haidian District, Beijing since Sep 2011
Business Analyst
N/A Independent Dec 2010 - Dec 2010
Private Placement Agent
Rainbow Nov 2009 - Aug 2010
assistant manager
Business Analyst
N/A Independent Dec 2010 - Dec 2010
Private Placement Agent
Rainbow Nov 2009 - Aug 2010
assistant manager
Education:
University of Bridgeport 2007 - 2009
MBA, MBA
MBA, MBA
Landscape Designer
View pageWork:
Snøhetta
Landscape Designer
Landscape Designer
Chao Li
View page
Chao Li
View page
Chao Li
View page
Chao Li
View page
Chao Li
View page
Chao Li
View pageLocation:
United States
Business Records
Name / Title
Company / Classification
Phones & Addresses
MEBOOKS, LLC
Publications
Us Patents
Designer Alpha 6-Fucosidase Mutants Enable Direct Core Fucosylation Of Intact N-Glycopeptides And N-Glycoproteins
View pageUS Patent:
20190185898, Jun 20, 2019
Filed:
Aug 10, 2017
Appl. No.:
16/323355
Inventors:
- College Park MD, US
CHAO LI - COLLEGE PARK MD, US
SHILEI ZHU - HALETHORPE MD, US
CHAO LI - COLLEGE PARK MD, US
SHILEI ZHU - HALETHORPE MD, US
Assignee:
UNIVERSITY OF MARYLAND, BALTIMORE COUNTY - BALTIMORE MD
International Classification:
C12P 21/00
Abstract:
The present invention provides for novel fucosidase mutants that server as fuco-ligases for core fucosylation of a range of biological glycopeptides and glycoproteins including intact therapeutic antibodies. Several mutants with mutation at the general acid/base residue E274 of the α1,6-fucosidase, including E274A, E274S, and E274G, were able to efficiently fucosylate a wide variety of complex N-glycopeptides and intact glycoproteins. The site specific mutants enable the transfer of fucose to a core GlcNAc-Asn residue and useful for drug delivery and vaccine development.